258 related articles for article (PubMed ID: 22993733)
21. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.
Park SW; Um SH; Lee HA; Kim SH; Sim Y; Yim SY; Seo YS; Ryu HS
Clin Mol Hepatol; 2016 Jun; 22(2):281-5. PubMed ID: 27246353
[TBL] [Abstract][Full Text] [Related]
22. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
World J Gastroenterol; 2017 Sep; 23(33):6030-6048. PubMed ID: 28970719
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic strategies for autoimmune hepatitis.
Manns MP; Strassburg CP
Dig Dis; 2011; 29(4):411-5. PubMed ID: 21894012
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis.
Fernandes NF; Redeker AG; Vierling JM; Villamil FG; Fong TL
Am J Gastroenterol; 1999 Jan; 94(1):241-8. PubMed ID: 9934764
[TBL] [Abstract][Full Text] [Related]
25. The use of immunosuppression in autoimmune hepatitis: A current literature review.
Cropley A; Weltman M
Clin Mol Hepatol; 2017 Mar; 23(1):22-26. PubMed ID: 28288505
[TBL] [Abstract][Full Text] [Related]
26. Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine.
de Boer NK; van Nieuwkerk CM; Aparicio Pages MN; de Boer SY; Derijks LJ; Mulder CJ
Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):457-61. PubMed ID: 15756101
[TBL] [Abstract][Full Text] [Related]
27. The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.
Baven-Pronk AM; Coenraad MJ; van Buuren HR; de Man RA; van Erpecum KJ; Lamers MM; Drenth JP; van den Berg AP; Beuers UH; den Ouden J; Koek GH; van Nieuwkerk CM; Bouma G; Brouwer JT; van Hoek B
Aliment Pharmacol Ther; 2011 Aug; 34(3):335-43. PubMed ID: 21668459
[TBL] [Abstract][Full Text] [Related]
28. Evolving new therapies of autoimmune hepatitis.
Vierling JM; Flores PA
Clin Liver Dis; 2002 Aug; 6(3):825-50, ix. PubMed ID: 12362583
[TBL] [Abstract][Full Text] [Related]
29. AIH: Which Alternative for Difficult-to-Treat Patients?
Sebode M; Schramm C
Dig Dis; 2015; 33 Suppl 2():83-7. PubMed ID: 26641096
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of Autoimmune Hepatitis].
Kim JK
Korean J Gastroenterol; 2023 Feb; 81(2):72-85. PubMed ID: 36824035
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune hepatitis: Unveiling faces.
Zhu JY; Han Y
J Dig Dis; 2015 Sep; 16(9):483-8. PubMed ID: 26332151
[TBL] [Abstract][Full Text] [Related]
32. Current and future treatments of autoimmune hepatitis.
Czaja AJ
Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):269-91. PubMed ID: 19485809
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
[TBL] [Abstract][Full Text] [Related]
34. [Autoimmune hepatitis: new diagnostic and therapeutic approach].
Prelipcean CC; Mihai C; Stefănescu C; Drug VL
Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):32-9. PubMed ID: 15688753
[TBL] [Abstract][Full Text] [Related]
35. Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.
Yu ZJ; Zhang LL; Huang TT; Zhu JS; He ZB
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):873-877. PubMed ID: 31150366
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.
Czaja AJ
Dig Dis Sci; 2012 Sep; 57(9):2248-66. PubMed ID: 22562533
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy.
Roberts SK; Lim R; Strasser S; Nicoll A; Gazzola A; Mitchell J; Siow W; Khoo T; Hamarneh Z; Weltman M; Gow P; Janko N; Tse E; Mishra G; Cheng EH; Levy M; Cheng W; Sood S; Skoien R; Mitchell J; Zekry A; George J; MacQuillan G; Wigg A; Stuart K; Sievert W; McCaughan G;
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):268-277. PubMed ID: 29050991
[TBL] [Abstract][Full Text] [Related]
38. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.
Efe C; Taii HA; Ytting H; Aehling N; Bhanji RA; Hagström H; Purnak T; Muratori L; Werner M; Muratori P; Klintman D; Schiano TD; Montano-Loza AJ; Berg T; Larsen FS; Alkhouri N; Ozaslan E; Heneghan MA; Yoshida EM; Wahlin S
Dig Dis Sci; 2018 May; 63(5):1348-1354. PubMed ID: 29569003
[TBL] [Abstract][Full Text] [Related]
39. [Autoimmune hepatitis-standard and second-line therapy].
Taubert R; Jaeckel E
Internist (Berl); 2018 Jun; 59(6):536-543. PubMed ID: 29725696
[TBL] [Abstract][Full Text] [Related]
40. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine.
Andries S; Casamayou L; Sempoux C; Burlet M; Reding R; Bernard Otte J; Buts JP; Sokal E
Transplantation; 2001 Jul; 72(2):267-72. PubMed ID: 11477351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
